Young Adult With Congenital Heart Disease Has Completed Three Marathons…and Counting
Alexa, born with tetralogy of Fallot, thrives today as a nurse and marathon runner thanks to adult congenital heart disease care at Mass General Brigham.
Call us to learn more, or request an appointment online.
Transcatheter aortic valve replacement (also known as TAVR or TAVI) is a minimally invasive procedure used by physicians at the Massachusetts General Hospital Corrigan Minhean Heart Center to treat patients with aortic valve stenosis.
Patients who have severe aortic stenosis (a narrowing of the valve that restricts blood flow) and are considered high risk or non-operable for open-heart surgery may be candidates for the transcatheter aortic valve replacement (also known as TAVR or TAVI) procedure.
During this procedure, physicians use minimally invasive techniques to implant a new heart valve without open-heart surgery. Physicians use a transfemoral (from the leg), transaxillary (from the shoulder), or transapical (through the chest) approach, by inserting a transcatheter heart valve that is mounted and crimped onto a balloon delivery catheter. It is then threaded through the patient’s circulatory system and directly into the heart’s pumping chamber.
Upon reaching the site of the patient’s diseased heart valve, the balloon expands, and the transcatheter heart valve is deployed across the patient’s diseased valve. This procedure is performed on a beating heart, meaning that there is no need for a cardiopulmonary bypass and its associated risks.
Transcatheter aortic valve replacement has been proven to have superior safety and efficacy and is currently approved by the US Food and Drug Administration for patients with aortic valve stenosis that are at high or extreme risk for open-heart surgery. Healthier patients may have an opportunity to receive transcatheter aortic valve replacement through one of our ongoing clinical studies.
Our multidisciplinary care team includes cardiac surgeons, interventional cardiologists, noninvasive cardiologists, cardiac anesthesiologists, cardiac imaging specialists, nurse practitioners, registered nurses and technicians with robust experience in the evaluation and treatment of patients with valvular heart disease. Patients referred to us undergo a thorough evaluation in order to determine the treatment option that would be best for the patient. Specifically, all patients being considered for TAVR will receive:
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2025-2026.
Our physicians welcome second opinion appointments to review cases and proposed lines of treatment.
Alexa, born with tetralogy of Fallot, thrives today as a nurse and marathon runner thanks to adult congenital heart disease care at Mass General Brigham.
Did you know that your mental well-being affects more than just your mood? New research shows that living with depression or anxiety may put your heart at risk, too.
J. Sawalla Guseh, MD, a Mass General Brigham sports cardiologist and director of the Cardiovascular Performance Program at Massachusetts General Hospital, explains that your heart rate is a key metric for improving your fitness.
Researchers from Mass General Brigham will present discoveries and outcomes from clinical trials and research studies for cardiovascular conditions, including heart disease and heart failure, at the European Society of Cardiology (ESC) Congress, being held in Madrid, Spain, from Aug. 29–Sept. 1.
Uncontrolled blood pressure puts people at increased risk of developing heart disease, brain disease, and kidney disease, yet only one in four people have their blood pressure under good control.
New study shows that being sedentary increases the risk of the most common types of heart disease, even among those who get enough exercise
Call us to learn more, or request an appointment online.